Aims and Backaround: The orbit is an uncommon primary site for non-Hod
gkin's lymphomas (NHL), and it accounts for less than 1% of all sites
of primary presentations. We report the experience of the Department o
f Radiation Oncology at Ankara University Faculty of Medicine with rad
iation therapy in treatment of patients with stage 1 primary orbital N
HL. Methods: From February 1978 through August 1993, 14 patients with
stage I primary orbital NHL were treated with radiation therapy. Accor
ding to the Working Formulation classification, 8 patients had low-gra
de and 6 had intermediate-grade lymphomas. The most commonly used radi
ation therapy technique was a single anterior field with a Cobalt-60 u
nit, delivering 40 Gy in 2 Gy daily fractions. Two patients with inter
mediate-grade lymphomas received the CHOP regimen following radiation
therapy. Results: Follow-up ranged from 0.8 to 18.3 years (median, 10.
3 years). Local control was achieved in all patients. Two patients wit
h low-grade lymphomas relapsed locally and were successfully salvaged
with radiation therapy. Three patients with intermediate-grade lymphom
as failed systemically. Salvage therapy consisted of combination chemo
therapy for 2 of them but was unsuccessful. Overall survival probabili
ties at 2, 5 and 10 years were 78.6%, 61.1% and 52.4%, respectively, f
or the entire group of 14 patients. Overall, cause-specific and diseas
e-free survival probabilities were higher for patients with low-grade
lymphomas than for those with intermediate-grade lymphomas (P = 0.03,
P = 0.03 and P = 0.06, respectively). Cataracts were observed in 9 and
lacrimal disorders in 4 patients. Conclusions: The study suggests tha
t among stage I primary orbital NHL, low-grade lymphomas could be trea
ted with radiation therapy alone, whereas combination chemotherapy cou
ld accompany radiation therapy for intermediate-grade lymphomas.